Office of the Director, National Institutes of Health; Notice of Meeting, 71342 [2022-25389]

Agencies

• DEPARTMENT OF HEALTH AND HUMAN SERVICES
• National Institutes of Health

[Federal Register Volume 87, Number 224 (Tuesday, November 22, 2022)]
[Notices]
[Page 71342]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-25389]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Office of the Director, National Institutes of Health; Notice of 
Meeting

    Pursuant to section 10(a) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meetings of the 
Advisory Committee to the Director, National Institutes of Health.
    The meetings will be open to the public as indicated below, with 
attendance limited to space available. Individuals who plan to attend 
as well as those who need special assistance, such as sign language 
interpretation or other reasonable accommodations, should notify the 
Contact Person listed below in advance of the meeting. The meeting 
sessions will be videocast and can be accessed from the NIH 
Videocasting website (https://videocast.nih.gov/).

    Name of Committee: Advisory Committee to the Director, National 
Institutes of Health.
    Date: December 8, 2022.
    Time: 9:00 a.m. to 5:15 p.m.
    Agenda: Performing the Duties of the NIH Director's Report; 
Updates on ARPA-H and COVID-19; Perspectives on the Current 
Cooperation with NIH and Priorities for the Future; Proposed Changes 
to Peer Review Criteria; ACD Working Group Updates; Other Business 
of the Committee.
    Date: December 9, 2022.
    Time: 9:00 a.m. to 3:15 p.m.
    Agenda: HeLA Genome Data Access Requests; NIH RECOVER 
Initiative; NIH Efforts in Support of Open Data; Diversity, Equity, 
Inclusion and Accessibility (DEIA) Strategic Plan; ACD Working Group 
Updates; Update on UNITE; Other Business of the Committee.
    Place: National Institutes of Health, Building 1, Wilson Hall, 
One Center Drive, Bethesda, MD 20892.
    Contact Person: Cyndi Burrus-Shaw, Staff Assistant, National 
Institutes of Health, Office of the Director, One Center Drive, 
Building 1, Room 126, Bethesda, MD 20892, 301-496-2433, 
[email protected].

    Any interested person may file written comments with the 
committee by forwarding the statement to the Contact Person listed 
on this notice. The statement should include the name, address, 
telephone number and when applicable, the business or professional 
affiliation of the interested person.
    In the interest of security, NIH has procedures at https://www.nih.gov/about-nih/visitor-information/campus-access-security for 
entrance into on-campus and off-campus facilities. All visitor 
vehicles, including taxicabs, hotel, and airport shuttles will be 
inspected before being allowed on campus. Visitors attending a 
meeting on campus or at an off-campus federal facility will be asked 
to show one form of identification (for example, a government-issued 
photo ID, driver's license, or passport) and to state the purpose of 
their visit.
    Additional Health and Safety Guidance: Before attending a 
meeting at an NIH facility, it is important that visitors review the 
NIH COVID-19 Safety Plan at https://ors.od.nih.gov/sr/dohs/safety/NIH-covid-19-safety-plan/Pages/default.aspx for information about 
requirements and procedures for entering NIH facilities, especially 
when COVID-19 community levels are medium or high. In addition, the 
Safer Federal Workforce website has FAQs for visitors at https://www.saferfederalworkforce.gov/faq/visitors/. Please note that if an 
individual has a COVID-19 diagnosis within 10 days of the meeting, 
that person must attend virtually. (For more information please read 
NIH's Requirements for Persons after Exposure at https://ors.od.nih.gov/sr/dohs/safety/NIH-covid-19-safety-plan/COVID-assessment-testing/Pages/persons-after-exposure.aspx and What 
Happens When Someone Tests Positive at https://ors.od.nih.gov/sr/dohs/safety/NIH-covid-19-safety-plan/COVID-assessment-testing/Pages/test-positive.aspx.) Anyone from the public can attend the open 
portion of the meeting virtually via the NIH Videocasting website 
(https://videocast.nih.gov). Please continue checking these websites, 
in addition to the committee website listed below, for the most up 
to date guidance as the meeting date approaches.
    Information is also available on the Institute's/Center's home 
page: https://acd.od.nih.gov, where an agenda and any additional 
information for the meeting will be posted when available.

(Catalogue of Federal Domestic Assistance Program Nos. 93.14, 
Intramural Research Training Award; 93.22, Clinical Research Loan 
Repayment Program for Individuals from Disadvantaged Backgrounds; 
93.232, Loan Repayment Program for Research Generally; 93.39, 
Academic Research Enhancement Award; 93.936, NIH Acquired 
Immunodeficiency Syndrome Research Loan Repayment Program; 93.187, 
Undergraduate Scholarship Program for Individuals from Disadvantaged 
Backgrounds, National Institutes of Health, HHS)

    Dated: November 16, 2022.
David W. Freeman,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2022-25389 Filed 11-21-22; 8:45 am]
BILLING CODE 4140-01-P